Oncology Trial eCOA Playbook: What Every Sponsor Needs to Know

Learn how to select and implement the right eCOA platform for the complex demands of oncology research.

Oncology trials are unlike any other—and your eCOA strategy should reflect that. From multi-arm protocols to treatment-related toxicity and frequent mid-study amendments, oncology trials demand flexible, high-performing tools that keep data quality and participant engagement intact. Yet many electronic Clinical Outcome Assessment (eCOA) platforms fall short when it comes to supporting the operational realities of cancer research. That’s why we created this free playbook for clinical operations teams as they evaluate eCOA solutions.

What You’ll Learn in This Oncology eCOA Playbook

What makes oncology trials uniquely complex from a data capture perspective

How to select an eCOA platform that supports global scale, protocol amendments, and unique participant needs

A real-world case study showing eCOA success in a global multiple myeloma Phase 3 trial

Common eCOA pitfalls in oncology trial execution to avoid

Access this important playbook today!

“By selecting eCOA platforms with the specialized capabilities detailed throughout this playbook, sponsors position their oncology programs for operational excellence and scientific success.”

— Karl McEvoy, PhD, VP, eCOA & Patient Technologies, YPrime